Incorporating valuable microbiome data into drug development pipeline

A newly launched collaborative project is being run under the umbrella of the Pistoia Alliance and funded by alliance members: Bayer, BMS, Eagle Genomics, Pfizer, Roche and Takeda. The "pre-competitive microbiome and drug metabolism project" aims to gather all existing microbiome data to create a global standardised ‘atlas’ that scientists can refer to.